pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›DESMODA
drug · protein
save

DESMODA

updated 3mo ago
by $ETON Eton Pharmaceuticals, Inc.🔗 ChEMBL
community read0 votes

🐶 often sniffed alongside

top 5
  • tagApproval6 co-mentions · 2 sources
  • drugdesmopressin acetate4 co-mentions · 3 sources
  • tagSmall Molecule2 co-mentions · 1 sources
  • companyApotex Corp1 co-mentions · 1 sources
  • tagDrug Shortage1 co-mentions · 1 sources

Protein drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 3 investigational indications.

targets

Vasopressin receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand
DESMODA
trade names
Concentraid, Ddavp, Ddavp (needs no refrigeration), Desmomelt, Desmopressin acetate, Desmopressin acetate (needs no refrigeration)
generic
DESMOPRESSIN ACETATE
MOA
12.1 Mechanism of Action Desmopressin acetate’s primary pharmacodynamic action involves its binding to vasopressin 2 (V2) receptors. V2 receptors are primarily located in the distal convoluted tubule and collecting ducts of the nephron in the kidneys. These receptors play a crucial role in regulating water reabsorption and urine concentration. By influencing the permeability of the renal tubules, V2 receptors help maintain the body’s water balance and overall homeostasis.
indication
1 INDICATIONS AND USAGE DESMODA is indicated for the management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. Limitations of Use • DESMODA is not indicated for the treatment of nephrogenic diabetes insipidus. DESMODA is a vasopressin analog indicated for the management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. Limitations of Use • DESMODA is not indicated for the treatment of nephrogenic diabetes insipidus.
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 23m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?